4//SEC Filing
Royer Scott E. 4
Accession 0000891839-19-000033
CIK 0001205922other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:34 PM ET
Size
8.0 KB
Accession
0000891839-19-000033
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Royer Scott E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-02-07$5.05/sh+1,725$8,711→ 3,999 total - Purchase
Common Stock
2019-02-06$4.57/sh+275$1,257→ 2,274 total
Holdings
- 25,000
Stock option (right to buy)
Exercise: $13.60Exp: 2028-02-21→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.75 to $5.17 per share, inclusive. Mr. Royer undertakes to provide to Vaccinex, Inc., any securityholder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]This option initially vests in quarterly installments of 1,526 shares for each of four quarters beginning on May 21, 2018. The remainder vests in three equal annual installments beginning February 21, 2020.
Documents
Issuer
VACCINEX, INC.
CIK 0001205922
Entity typeother
Related Parties
1- filerCIK 0001747756
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:34 PM ET
- Size
- 8.0 KB